SL Swiss Lipid Navigator
Demonstration prototype — synthetic data only, simplified rules, not for clinical use.
Step 10 of 10 · Decision support

Summary

What this step shows

All results for this patient in one view, with the reasoning behind each step. Update any value and the results are recalculated.

Peter Zimmermann
PT-0003 · 77 years · Male · born 22.11.1948 · LDL-C measured 12.08.2026
Update lab values
Clinical pathwayPrimary Prevention — Older-person pathway
Risk categoryHigh
LDL-C (current)3.2 mmol/L
LDL-C target<1.8 mmol/L
Current treatmentModerate-intensity statin (Simvastatin 40 mg)
Recommended next stepEscalate to a high-intensity statin
Swiss reimbursement Not applicable at this stage
Reasoning by step
  1. Step 5 — Clinical pathway View details →
    Primary Prevention — Older-person pathway

    No CVD, no FH, no diabetes, age 65+: uses the age-adjusted primary-prevention risk methodology.

  2. Step 6 — Cardiovascular risk View details →
    High

    Simplified demo scoring (age + smoking + blood pressure + baseline LDL-C) → 5 points → High risk. This is illustrative only, not the licensed ESC calculator.

  3. Step 7 — LDL-C target View details →
    <1.8 mmol/L

    High risk → target <1.8 mmol/L.

  4. Step 8 — Treatment plan View details →
    Escalate to a high-intensity statin

    On a statin, but not yet at high intensity, and no intolerance recorded — escalate the dose/potency first.

  5. Step 9 — Swiss reimbursement View details →
    Not applicable at this stage

    This engine only activates once a PCSK9 inhibitor (or another reimbursement-restricted therapy) is clinically proposed. For this patient, the Treatment Engine recommended a different next step, so no reimbursement check is needed yet.

Demonstration output based on simplified rules — not clinical advice. Generated 07.11.2026 17:14.

← Swiss reimbursement
Back to patients →